Supplementary Materials and Methods

Patient recruitment and clinical evaluation
The study was performed in compliance with the tenets of the WMA Declaration of Helsinki. Study participants diagnosed either with BCM or XLCD were recruited ad hoc at different centers specialized in inherited retinal diseases during routine clinical diagnostics. All participants gave written informed consent -approved by the respective local research and ethical review boards -for participation in the study for which blood or DNA samples were sent to Tuebingen for genetic analysis. Procedures of the genetic analysis were approved by the Ethics Committee of the Medical Faculty, Eberhard-Karls University Tuebingen. Patients underwent basic ophthalmologic examination at the different clinical centers which included evaluation of ocular motility and slit lamp examination of the anterior segment, visual acuity (VA), refraction, colour vision and visual field testing, assessment of retinal morphology applying imaging technologies such as funduscopy, optical coherence tomography (OCT), autofluorescence imaging, and ERG recordings under scotopic and photopic conditions.
Genotyping of the MW/LW gene cluster
Genomic DNA was isolated from blood samples according to standard procedures. The structure and integrity of the LW/MW gene cluster (e.g. single versus multiple opsin gene copies, presence of hybrid genes) on the X-chromosome was investigated by a two-step genotyping protocol. First, we used a protocol that screens for mutations most commonly found in BCM/XLCD patients and specifically tests for large genomic deletions at the OPN1LW/OPN1MW gene cluster and the upstream locus control region (LCR), the presence of single or multiple opsin gene copies, and the presence or absence of the common point mutation c.607T>C, p.C203R. Briefly, duplex PCRs including primers for the tested fragment and an autosomal control fragment were performed for: 1) a sequence defined as the common overlap of known deletions of the LCR (Nathans et al., 1989 (Nathans et al., , 1993 ; 2) the OPN1LW promoter; and 3) the OPN1MW promoter to test for large genomic deletions and the presence of single or multiple opsin gene copies. In addition, two PCR fragments for exons 4 and 5, respectively, for both OPN1LW and OPN1MW were amplified and digested with BstUI and RsaI, respectively. The restriction fragment length polymorphism (RFLP) in exon 4 via BstUI analysed for the c.607T>C p.C203R mutation (RFLP positive cases are further validated by Sanger sequencing), while the RFLP in exon 5 via RsaI addressed the dimorphism at amino acid position 277 -p.Y277 being specific for the OPN1LW gene, and p.F277 for the OPN1MW gene. The second screening step analyzed for other deleterious point mutations or haplotypes for those subjects either single or multiple structurally intact gene copies by PCR and Sanger-sequencing. Specific long distance PCRs (LD-PCRs) were performed with primers LCR1F (5'-CACCCTTCTGCAAGAGTGTGGG-3') and RGCP2-5R (5'-GCGGACTAGTGATCTGCTGATGGTGTTGCTTA-3') for the proximal gene copy, and E1G-F (5'-GAGTACAGGTATTTGCCACTAAGC-3') and RGCP2-5R for distal gene copies. LD-PCR products were directly sequenced with internal primers or re-amplified with exon-specific primers prior to sequencing. PCR products were purified by ExoSAP-IT treatment (Affymetrix, Santa Clara, CA) and cycle-sequenced applying BigDye Terminator V1.1 chemistry (Life Technologies, Darmstadt, Germany). For the determination of exon 3 haplotypes we amplified a 400 bp fragment using primers BCM-Ex3-F (5'-TGGTGGAAAGAAAGATGTCG-3') and BCM-Ex3-R (5'-GCCCAGAGAAAGGAAGTGATT-3') that was subsequently sequenced directly or after an intermitting cloning step if multiple mixed base positions were observed.
For subjects with multiple gene copies, the total number of LW/MW opsin genes was determined by means of real-time quantitative PCR (qPCR) with genomic DNA as template. We used two different TaqMan assays that target different parts of the LW/MW genes: the HS_01912094 assay (Life Technologies) targeting exon 6, and a custom-designed TaqMan Number Reference Assay; Life Technologies). We used a series of male controls with defined LW/MW copy number [n=1-6; (4)] to generate a copy number dependent Ct calibration curve. All three assays were performed in triplicate for each sample. Obtained Ct values were used to infer copy numbers from the calibration curves.
Minigene Constructs
A HindIII site in the polylinker of the prototype construct was eliminated for the present study by means of inverse PCR with primers NotI-Inv3-Rv (5'-AAAAAAGCGGCCGCTGACGGTTCACTAAACGAGCTCT-3') and NotI-Inv3-Fw (5'-AAAAAAGCGGCCGCCGGATCCGGTACCATGGCCCAGCA-3'), followed by digestion with NotI and re-circulation. Derived minigenes with novel exon 3 haplotypes were generated by replacing a 279 bp HindIII-AflII fragment with a homologous fragment from defined subject obtained through PCR amplification with primers BCM-Ex3-r and BCM-Ex3-f and digestion with HindIII and AflII. Alternatively, PCR products were first cloned in pCR2.1 (TA Cloning Kit, Invitrogen, Life technologies) before excision of the HindIII-AflII fragment and replacement cloning into the revised prototype construct. In vitro mutagenesis with primers IVM-Ex3-174t-Fw (5'-TGGCCATCGTGGGCATTGTCTTCTCCTGGATCTG-3') and IVM-Ex3-174t-Rv (5'-CAGATCCAGGAGAAGACAATGCCCACGATGGCCA-3') was performed to obtain the haplotype 'LVVIA'. All constructs were verified by Sanger sequencing.
Transfection and RNA extraction
HEK293 cells were routinely maintained in Dulbecco´s modified Eagle´s medium, DMEM (Gibco, Life Technologies) supplemented with 10% fetal bovine serum (FBS; Gibco, Life Technologies), PenicillinStreptomycin (Sigma-Aldrich Chemie GmbH) at 100 µg/ml, and Amphotericin B (Biochrom GmbH) at 2.5 µg/ml. Cells were seeded in 6-well plates in DMEM with 10% FBS and the following day, at 80-90% confluency, cells were transfected with 4 µg DNA of the minigene construct using 20 µl Lipofectamine 2000 per well and OptiMEM® supplemented with GlutaMAX TM (Life Technologies) as diluents and medium. After 6 h incubation, cells were harvested by trypsinization with 0.05% Trypsine-EDTA (Gibco, Life Technologies), centrifuged at 1500 rpm for 5 min and transferred to a 6 cm dish with DMEM supplemented with 10% FCS and antibiotics. 24 h post-transfection, cells were lysed and total RNA was extracted applying the peqGOLD Total RNA Kit (PEQLAB Biotechnologie GmbH).
RT-PCR and relative quantification
First strand cDNA synthesis was performed using 2 µg of total RNA and random hexamer primers, 
Microsatellite analysis
Centromeric (DXS8011, DXS8103, DXS1356, DXS8087) and telomeric (L441TA, L441CA, AF277A, AF277B and DXS1073) markers to the LW/MW cluster were used to genotype the three BCM72 family members (see Figure. 4A, Supplementary Table S2 and Supplementary Fig. S1 ). Primers were labeled either with TET, HEX or FAM. Standard PCR reactions were performed with 50-100 ng of genomic DNA. PCR products were diluted 2-10 fold with water, mixed with GeneScan ROX500 size standard and Hi-Di Formamide, and separated by capillary electrophoresis. GeneMapper 5 Software was used for allele calling.
Markers for which the mother BCM72-II:1 was heterozygous were used to reconstruct haplotypes.
Mapping of the gene conversion event
LD-PCRs were performed for all three members of BCM72 using primers LCR1F and RGCP2-5R for the proximal gene copy, and E1G-F and RGCP2-5 for the distal copies. Upon AvrII-KpnI digestion, the resulting 7494 bp and 6211 bp fragments from LW (intron 1 to intron 5) and MW (intron 1 to intron 4) respectively, were purified with CHROMA SPIN+TE-1000 columns (Takara Bio Europe) and ligated to
XbaI-KpnI double-digested pGEM3Zf(+). We selected two independent clones of the following gene copies for further analysis: (1) LW-derived clones bearing the 'LIAVA' haplotype from subjects BCM72-II:1 and BCM72-III:1, (2) MW-derived clones bearing the 'LIAVA' haplotype from subject BCM72-I:1, and (3) LWderived clones bearing the 'LIAVS' haplotype from subject BCM72-I:1. We sequenced exon 3 and flanking introns in these clones by means of primer walking.
Bioinformatic predictions and reference sequences
In silico splicing predictions were performed with SROOGLE (http://sroogle.tau.ac.il/) (28 Figure S2 : Mapping of the outermost borders of the gene conversion event in family BCM72. The maximal converted tract in family BCM72 is delimited by SNPs rs3788802 (c.409+949G>A) in intron 2 and rs69018729 (c.578+91G>A) in intron 3, for which the 'LIAVA' bearing MW gene copy in BCM72-I:1 differs from the LW gene copies in subjects BCM72-I:1, BCM72-II:2 and BCM72-III:1. Note that the gene conversion event converts the 'LIAVS' bearing LW gene copy in BCM72-I:1 into a 'LIAVA' bearing LW copy that is transmitted to the mother and the grandson.
